These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12052203)

  • 21. Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
    Bhattacharya P; Leonard JT; Roy K
    J Mol Model; 2005 Nov; 11(6):516-24. PubMed ID: 15928917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Conformer Descriptors for QSAR Modeling.
    Nikonenko A; Zankov D; Baskin I; Madzhidov T; Polishchuk P
    Mol Inform; 2021 Nov; 40(11):e2060030. PubMed ID: 34342944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecotoxicological QSAR modeling of organic compounds against fish: Application of fragment based descriptors in feature analysis.
    Khan K; Baderna D; Cappelli C; Toma C; Lombardo A; Roy K; Benfenati E
    Aquat Toxicol; 2019 Jul; 212():162-174. PubMed ID: 31128417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
    Liu H; Papa E; Gramatica P
    Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolutionary computation and QSAR research.
    Aguiar-Pulido V; Gestal M; Cruz-Monteagudo M; Rabuñal JR; Dorado J; Munteanu CR
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):206-25. PubMed ID: 23700999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A computationally based identification algorithm for estrogen receptor ligands: part 1. Predicting hERalpha binding affinity.
    Bradbury S; Kamenska V; Schmieder P; Ankley G; Mekenyan O
    Toxicol Sci; 2000 Dec; 58(2):253-69. PubMed ID: 11099638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A CoMFA analysis with conformational propensity: an attempt to analyze the SAR of a set of molecules with different conformational flexibility using a 3D-QSAR method.
    Gohda K; Mori I; Ohta D; Kikuchi T
    J Comput Aided Mol Des; 2000 Mar; 14(3):265-75. PubMed ID: 10756481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening.
    de Julian-Ortiz JV
    Comb Chem High Throughput Screen; 2001 May; 4(3):295-310. PubMed ID: 11375744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Dynamic' QSAR for semicarbazide-induced mortality in frog embryos.
    Mekenyan OG; Schultz TW; Veith GD; Kamenska V
    J Appl Toxicol; 1996; 16(4):355-63. PubMed ID: 8854223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategic selection of chemicals for testing. Part I. Functionalities and performance of basic selection methods.
    Aladjov H; Todorov M; Schmieder P; Serafimova R; Mekenyan O; Veith G
    SAR QSAR Environ Res; 2009; 20(1-2):159-83. PubMed ID: 19343590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors.
    Kovatcheva A; Golbraikh A; Oloff S; Feng J; Zheng W; Tropsha A
    SAR QSAR Environ Res; 2005; 16(1-2):93-102. PubMed ID: 15844445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
    Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-QSAR: a database of 18,000 QSARs and associated biological and physical data.
    Kurup A
    J Comput Aided Mol Des; 2003; 17(2-4):187-96. PubMed ID: 13677485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
    Waller CL
    J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR of conformationally flexible molecules: comparative molecular field analysis of protein-tyrosine kinase inhibitors.
    Nicklaus MC; Milne GW; Burke TR
    J Comput Aided Mol Des; 1992 Oct; 6(5):487-504. PubMed ID: 1474396
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.